{"gene":"DUSP23","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2004,"finding":"DUSP23 (VHZ) was identified as the smallest active protein-tyrosine phosphatase known (150 residues), containing a DSPc domain but lacking a CH2 domain. It was shown to be enzymatically active, dephosphorylating phospho-tyrosine and phospho-threonine substrates including p-nitrophenyl phosphate and p44ERK1 (but not p38 or p54SAPKbeta) in vitro. In transfected HEK293 cells, DUSP23 localizes to the cytoplasm.","method":"In vitro phosphatase assay with pNPP and oligopeptides; in vitro dephosphorylation of p44ERK1; RT-PCR expression analysis; transient transfection with subcellular localization","journal":"The international journal of biochemistry & cell biology","confidence":"High","confidence_rationale":"Tier 1 — multiple in vitro activity assays with defined substrates, replicated by subsequent structural studies","pmids":["15147733"],"is_preprint":false},{"year":2004,"finding":"DUSP23 (VHZ) was independently characterized as the smallest active cysteine-based PTP, bearing the HCXXGXXRS(T) active site motif. It was shown to dephosphorylate phospho-Tyr and phospho-Ser/Thr residues and, unlike the related VHR, is unlikely to dephosphorylate MAP kinases based on surface charge distribution modeling. VHZ was found in cytosol and nucleoli of transfected cells.","method":"In vitro phosphatase assay; computer modeling of structure; subcellular localization in transfected cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 in vitro activity, Tier 4 structural (computational), single lab","pmids":["15201283"],"is_preprint":false},{"year":2008,"finding":"Crystal structure of DUSP23 (VHZ) was solved at 1.93 Å resolution, revealing a typical αβα PTP fold with a shallow active site cleft that supports dual-specificity. The Thr135-Tyr136 dipeptide from a symmetry-related molecule, together with a malate ion, occupied the active site mimicking the phosphorylated TY motif of the MAPK activation loop. Functional analysis of Phe66, Leu97, and Phe99 provided mechanistic insight into substrate binding and catalysis.","method":"X-ray crystallography (1.93 Å); enzyme-substrate/product complex analysis; functional mutagenesis of active site residues","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with enzyme-substrate/product complex and mutagenesis validation","pmids":["18245086"],"is_preprint":false},{"year":2010,"finding":"DUSP23 (VHZ) was shown to localize to the centrosome in addition to the cytoplasm, as demonstrated by indirect immunofluorescence of both exogenous and endogenous VHZ. Overexpression of VHZ (but not the catalytically inactive VHZ-C95S mutant) in MCF-7 cells promoted cell proliferation; shRNA-mediated knockdown increased G1 and decreased S phase cell populations, indicating that VHZ facilitates G1/S cell cycle transition in a phosphatase-activity-dependent manner.","method":"Indirect immunofluorescence; retroviral overexpression and shRNA knockdown; cell proliferation assay; cell cycle analysis by flow cytometry","journal":"Molecular cancer","confidence":"High","confidence_rationale":"Tier 2 — direct localization experiment with functional consequence, catalytic mutant control, multiple cell-based assays","pmids":["20509867"],"is_preprint":false},{"year":2010,"finding":"DUSP23 was identified as a phosphatase for GCM1, a transcription factor essential for placental development. DUSP23 interaction with GCM1 is enhanced by PKA-dependent phosphorylation of GCM1 on Ser269 and Ser275. Recruited DUSP23 reverses GSK-3β-mediated phosphorylation of GCM1 Ser322, which promotes GCM1 acetylation, stabilization, and transcriptional activation. Knockdown of DUSP23 suppressed GCM1 target gene expression and placental cell fusion.","method":"Co-immunoprecipitation; phosphorylation/dephosphorylation assays; shRNA knockdown; placental cell fusion assay; reporter gene assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, substrate dephosphorylation assay, KD with defined cellular phenotype (cell fusion), multiple orthogonal methods","pmids":["20855292"],"is_preprint":false},{"year":2015,"finding":"DUSP23 expression increases during neuronal differentiation of mouse embryonic stem cells. Knockdown of DUSP23 decreased neuronal differentiation as measured by reduced neuronal outgrowth and decreased expression of neuronal marker proteins and mRNAs.","method":"Expression profiling (RT-PCR/Western blot); shRNA knockdown; neuronal outgrowth assay; neuronal marker protein/mRNA quantification during differentiation","journal":"Neuroscience letters","confidence":"Medium","confidence_rationale":"Tier 2 — KD with defined cellular phenotype, but single lab and limited mechanistic pathway placement","pmids":["26704437"],"is_preprint":false},{"year":2016,"finding":"DUSP23 was identified as a phosphatase for β-catenin at Tyr142, promoting dephosphorylation of this residue and enhancing the interaction between α- and β-catenin. DUSP23 knockdown specifically diminished adhesion to E-cadherin (without altering fibronectin adhesion), produced 'zipper-like' cell-cell adhesions, caused defects in transmission of polarization cues, and reduced coordination during collective cell migration.","method":"Protein interaction mapping (affinity purification-MS); DUSP23 knockdown; β-catenin pTyr142 phosphorylation assay; E-cadherin adhesion assay; live-cell imaging of collective migration","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — substrate identified by AP-MS and validated by phospho-specific assay, KD with multiple defined cellular phenotypes","pmids":["27255161"],"is_preprint":false},{"year":2025,"finding":"DUSP23 promotes cancer stem cell-like properties and chemoresistance in non-small cell lung cancer by positively regulating STAT3 phosphorylation, thereby enhancing SOX2 transcription. DUSP23 knockdown impaired cell cluster formation under ultra-low adhesion conditions, suppressed SOX2 expression, decreased invasive behavior in cisplatin-resistant cells, and induced apoptosis. DUSP23 knockdown also suppressed lung tumorigenesis in vivo.","method":"shRNA knockdown; STAT3 phosphorylation assay; SOX2 transcription/protein assay; cluster formation assay; invasion assay; apoptosis assay; in vivo xenograft","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — KD with defined phenotype and pathway placement (STAT3/SOX2), single lab","pmids":["41257937"],"is_preprint":false},{"year":2025,"finding":"EZH2-mediated H3K27me3 enrichment on the DUSP23 promoter suppresses DUSP23 expression. When EZH2 is inhibited, DUSP23 expression is elevated. DUSP23 was shown by Co-IP and molecular docking to mediate dephosphorylation of pSMAD3 (Ser423/425), thereby attenuating macrophage-to-myofibroblast transition and kidney fibrosis in a nephrocalcinosis model.","method":"ChIP-seq; Co-immunoprecipitation; molecular docking; EZH2 knockout/inhibition (GSK-126); transcriptomic sequencing; immunofluorescence; flow cytometry","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP substrate identification (pSMAD3) with ChIP-based upstream regulation, single lab but multiple orthogonal methods","pmids":["39987296"],"is_preprint":false}],"current_model":"DUSP23 (VHZ) is a small (150 aa) catalytically active dual-specificity phosphatase with an αβα PTP fold and shallow active site that dephosphorylates phospho-Tyr and phospho-Ser/Thr residues on substrates including ERK1, GCM1 (Ser322), β-catenin (Tyr142), and pSMAD3 (Ser423/425); it localizes to the cytoplasm and centrosome, promotes G1/S cell cycle progression and cell proliferation in a catalytic-activity-dependent manner, coordinates GCM1 stabilization and placental cell fusion by counteracting GSK-3β phosphorylation, maintains E-cadherin-based adherens junctions through β-catenin dephosphorylation, supports neuronal differentiation, and promotes cancer stem cell-like properties and chemoresistance via STAT3/SOX2 signaling."},"narrative":{"teleology":[{"year":2004,"claim":"Identification of DUSP23 as the smallest active dual-specificity phosphatase established it as a bona fide enzyme capable of dephosphorylating pTyr and pThr substrates, including ERK1 but not p38 or SAPK, and placed it in the cytoplasm.","evidence":"In vitro phosphatase assays with pNPP, oligopeptide substrates, and recombinant p44ERK1; subcellular localization in transfected HEK293 cells; independent characterization confirming dual-specificity and noting cytosol/nucleolar localization","pmids":["15147733","15201283"],"confidence":"High","gaps":["In vivo substrates beyond ERK1 not yet identified","Physiological relevance of nucleolar localization not addressed","No structural data to explain substrate selectivity"]},{"year":2008,"claim":"The crystal structure at 1.93 Å resolution revealed how DUSP23's shallow active site cleft accommodates both pTyr and pSer/pThr substrates, resolving the structural basis for its dual specificity and identifying key catalytic residues (Phe66, Leu97, Phe99).","evidence":"X-ray crystallography with enzyme-substrate/product complex mimicked by Thr135-Tyr136 dipeptide and malate ion; functional mutagenesis of active-site residues","pmids":["18245086"],"confidence":"High","gaps":["No co-crystal with a physiological substrate","Structural basis for selectivity against p38/SAPK not fully resolved"]},{"year":2010,"claim":"Discovery of centrosomal localization and catalytic-activity-dependent promotion of G1/S transition answered how DUSP23 participates in cell proliferation and revealed a centrosome-associated function, while identification of GCM1 Ser322 as a substrate linked DUSP23 to placental cell fusion through antagonism of GSK-3β.","evidence":"Indirect immunofluorescence of endogenous/exogenous protein; catalytically dead C95S mutant control; shRNA knockdown with cell-cycle and cell-fusion phenotypes; Co-IP and dephosphorylation assays for GCM1","pmids":["20509867","20855292"],"confidence":"High","gaps":["Centrosomal substrate(s) not identified","Mechanism linking DUSP23 to G1/S regulators not defined","Whether GCM1 dephosphorylation is direct at physiological stoichiometry not fully confirmed"]},{"year":2015,"claim":"Demonstration that DUSP23 is upregulated during and required for neuronal differentiation of mouse embryonic stem cells extended its functional scope beyond proliferation to a developmental lineage commitment role.","evidence":"shRNA knockdown during mESC neuronal differentiation; neuronal outgrowth and marker expression quantification","pmids":["26704437"],"confidence":"Medium","gaps":["Downstream substrate(s) mediating the differentiation phenotype not identified","Not independently replicated","Limited mechanistic pathway placement"]},{"year":2016,"claim":"Identification of β-catenin Tyr142 as a direct DUSP23 substrate explained how it maintains E-cadherin-based adherens junctions and coordinates collective cell migration, establishing a cell-adhesion function.","evidence":"Affinity purification–mass spectrometry interaction mapping; pTyr142-specific phosphorylation assays; DUSP23 knockdown with E-cadherin adhesion, polarity, and migration phenotypes","pmids":["27255161"],"confidence":"High","gaps":["Whether DUSP23 regulates β-catenin transcriptional (Wnt) signaling in addition to adhesion not tested","Tissue-specific relevance of this function not explored"]},{"year":2025,"claim":"Two studies expanded DUSP23's substrate repertoire and disease-context roles: DUSP23 promotes cancer stemness and chemoresistance in NSCLC via STAT3/SOX2 signaling, and DUSP23 dephosphorylates pSMAD3 (Ser423/425) to attenuate macrophage-to-myofibroblast transition in kidney fibrosis, with its expression regulated by EZH2-mediated H3K27me3.","evidence":"shRNA knockdown in cisplatin-resistant NSCLC cells with in vivo xenograft; Co-IP and molecular docking for pSMAD3; ChIP-seq for EZH2-mediated promoter silencing; nephrocalcinosis model","pmids":["41257937","39987296"],"confidence":"Medium","gaps":["Paradoxical promotion of STAT3 phosphorylation by a phosphatase requires mechanistic explanation — indirect mechanism not delineated","pSMAD3 as substrate validated by Co-IP and docking but not by in vitro reconstitution with purified proteins","Both studies from single laboratories, awaiting independent replication"]},{"year":null,"claim":"How DUSP23 achieves substrate selectivity across its diverse substrates (ERK1, GCM1, β-catenin, SMAD3, STAT3 pathway), what its centrosomal substrate(s) are, and whether its apparently contradictory pro-phosphorylation effect on STAT3 is indirect remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No systematic substrate profiling or phospho-proteomics performed","Centrosomal interactors and substrates unknown","No in vivo genetic model (knockout mouse) reported"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,2,4,6,8]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,1]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[3]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,4,6,7,8]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[3]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[6]}],"complexes":[],"partners":["GCM1","CTNNB1","SMAD3","MAPK3"],"other_free_text":[]},"mechanistic_narrative":"DUSP23 (VHZ) is the smallest known catalytically active cysteine-based protein tyrosine phosphatase (150 residues), functioning as a dual-specificity phosphatase that dephosphorylates both phospho-Tyr and phospho-Ser/Thr residues on a growing list of substrates including ERK1, GCM1 (Ser322), β-catenin (Tyr142), and pSMAD3 (Ser423/425) [PMID:15147733, PMID:20855292, PMID:27255161, PMID:39987296]. Its crystal structure reveals an αβα PTP fold with a characteristically shallow active-site cleft that accommodates both pTyr and pSer/pThr substrates [PMID:18245086]. DUSP23 localizes to the cytoplasm and centrosome, promotes G1/S cell-cycle progression in a catalytic-activity-dependent manner, maintains E-cadherin-based adherens junctions through β-catenin Tyr142 dephosphorylation, coordinates GCM1 stabilization and placental cell fusion by counteracting GSK-3β phosphorylation, and supports neuronal differentiation [PMID:20509867, PMID:27255161, PMID:20855292, PMID:26704437]. In non-small cell lung cancer, DUSP23 promotes cancer stem cell-like properties and chemoresistance via positive regulation of STAT3 phosphorylation and SOX2 transcription [PMID:41257937]."},"prefetch_data":{"uniprot":{"accession":"Q9BVJ7","full_name":"Dual specificity protein phosphatase 23","aliases":["Low molecular mass dual specificity phosphatase 3","LDP-3","VH1-like phosphatase Z"],"length_aa":150,"mass_kda":16.6,"function":"Protein phosphatase that mediates dephosphorylation of proteins phosphorylated on Tyr and Ser/Thr residues. In vitro, it can dephosphorylate p44-ERK1 (MAPK3) but not p54 SAPK-beta (MAPK10) in vitro. Able to enhance activation of JNK and p38 (MAPK14)","subcellular_location":"Cytoplasm, cytosol; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9BVJ7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DUSP23","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DUSP23","total_profiled":1310},"omim":[{"mim_id":"618361","title":"DUAL-SPECIFICITY PHOSPHATASE 23; DUSP23","url":"https://www.omim.org/entry/618361"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DUSP23"},"hgnc":{"alias_symbol":["FLJ20442","DUSP25"],"prev_symbol":[]},"alphafold":{"accession":"Q9BVJ7","domains":[{"cath_id":"3.90.190.10","chopping":"8-148","consensus_level":"high","plddt":97.9582,"start":8,"end":148}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BVJ7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BVJ7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BVJ7-F1-predicted_aligned_error_v6.png","plddt_mean":97.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DUSP23","jax_strain_url":"https://www.jax.org/strain/search?query=DUSP23"},"sequence":{"accession":"Q9BVJ7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BVJ7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BVJ7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BVJ7"}},"corpus_meta":[{"pmid":"31766293","id":"PMC_31766293","title":"MAP4K Family Kinases and DUSP Family Phosphatases in T-Cell Signaling and Systemic Lupus Erythematosus.","date":"2019","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/31766293","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21314941","id":"PMC_21314941","title":"Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma.","date":"2011","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21314941","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20855292","id":"PMC_20855292","title":"Dual-specificity phosphatase 23 mediates GCM1 dephosphorylation and activation.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20855292","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15201283","id":"PMC_15201283","title":"The minimal essential core of a cysteine-based protein-tyrosine phosphatase revealed by a novel 16-kDa VH1-like phosphatase, VHZ.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15201283","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15147733","id":"PMC_15147733","title":"Molecular cloning and characterization of a novel dual-specificity phosphatase 23 gene from human fetal brain.","date":"2004","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15147733","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29294296","id":"PMC_29294296","title":"Integration of Murine and Human Studies for Mapping Periodontitis Susceptibility.","date":"2018","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/29294296","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18245086","id":"PMC_18245086","title":"Structure of human dual specificity protein phosphatase 23, VHZ, enzyme-substrate/product complex.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18245086","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20509867","id":"PMC_20509867","title":"VHZ is a novel centrosomal phosphatase associated with cell growth and human primary cancers.","date":"2010","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20509867","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27255161","id":"PMC_27255161","title":"A protein interaction map for cell-cell adhesion regulators identifies DUSP23 as a novel phosphatase for β-catenin.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27255161","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27737517","id":"PMC_27737517","title":"DUSP23 is over-expressed and linked to the expression of DNMTs in CD4+ T cells from systemic lupus erythematosus patients.","date":"2016","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27737517","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37291676","id":"PMC_37291676","title":"The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data.","date":"2023","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/37291676","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26704437","id":"PMC_26704437","title":"Profiling analysis of protein tyrosine phosphatases during neuronal differentiation.","date":"2015","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/26704437","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39987296","id":"PMC_39987296","title":"EZH2-mediated macrophage-to-myofibroblast transition contributes to calcium oxalate crystal-induced kidney fibrosis.","date":"2025","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/39987296","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36901962","id":"PMC_36901962","title":"Evidence for Extensive Duplication and Subfunctionalization of FCRL6 in Armadillo (Dasypus novemcinctus).","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36901962","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39442449","id":"PMC_39442449","title":"ACSL1 positively regulates adipogenic differentiation.","date":"2024","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/39442449","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41610418","id":"PMC_41610418","title":"Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.","date":"2026","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/41610418","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41257937","id":"PMC_41257937","title":"Targeting dual-specificity phosphatase 23 to overcome chemoresistance and stem cell-like behavior in non-small cell lung cancer cells.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41257937","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41096831","id":"PMC_41096831","title":"Candidate Transcript Panel in Semen Extracellular Vesicles Can Improve Prediction of Aggressiveness of Prostate Cancer.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41096831","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33845483","id":"PMC_33845483","title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33845483","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21145461","id":"PMC_21145461","title":"Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21145461","citation_count":318,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31056398","id":"PMC_31056398","title":"Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality.","date":"2019","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/31056398","citation_count":298,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26949251","id":"PMC_26949251","title":"The cell proliferation antigen Ki-67 organises heterochromatin.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26949251","citation_count":265,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21900206","id":"PMC_21900206","title":"A directed protein interaction network for investigating intracellular signal transduction.","date":"2011","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21900206","citation_count":258,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34800366","id":"PMC_34800366","title":"Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.","date":"2021","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34800366","citation_count":239,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17207965","id":"PMC_17207965","title":"hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes.","date":"2007","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17207965","citation_count":222,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27499296","id":"PMC_27499296","title":"Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27499296","citation_count":220,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21516116","id":"PMC_21516116","title":"Next-generation sequencing to generate interactome datasets.","date":"2011","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/21516116","citation_count":200,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32807901","id":"PMC_32807901","title":"UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32807901","citation_count":168,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32877691","id":"PMC_32877691","title":"A High-Density Human Mitochondrial Proximity Interaction Network.","date":"2020","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32877691","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31871319","id":"PMC_31871319","title":"Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31871319","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21630459","id":"PMC_21630459","title":"Proteomic characterization of the human sperm nucleus.","date":"2011","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/21630459","citation_count":116,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33658012","id":"PMC_33658012","title":"FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.","date":"2021","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33658012","citation_count":106,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33226137","id":"PMC_33226137","title":"Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy.","date":"2020","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/33226137","citation_count":100,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30429088","id":"PMC_30429088","title":"SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.","date":"2018","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/30429088","citation_count":93,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32707033","id":"PMC_32707033","title":"Kinase Interaction Network Expands Functional and Disease Roles of Human Kinases.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/32707033","citation_count":88,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10327,"output_tokens":2362,"usd":0.033205},"stage2":{"model":"claude-opus-4-6","input_tokens":5678,"output_tokens":2243,"usd":0.126697},"total_usd":0.346364,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":22683,"output_tokens":2621,"usd":0.053682},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6214,"output_tokens":2298,"usd":0.13278}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"DUSP23 (VHZ) is an active dual-specificity phosphatase that dephosphorylates phospho-tyrosine and phospho-threonine residues; it can dephosphorylate p44ERK1 but not p38 or p54SAPKbeta in vitro, and localizes to the cytoplasm of HEK293 cells.\",\n      \"method\": \"In vitro phosphatase assay with pNPP substrate and oligopeptides containing phospho-Tyr/Thr; RT-PCR for expression; transient transfection for localization\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 in vitro enzymatic assay; single lab, single paper\",\n      \"pmids\": [\"15147733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DUSP23/VHZ is the smallest catalytically active protein-tyrosine phosphatase (150 residues), containing only the minimal core PTP fold; it localizes to the cytosol and nucleoli in transfected cells; its surface charge distribution differs from VHR, making MAPK dephosphorylation unlikely.\",\n      \"method\": \"Computer modeling/structural analysis; transfection with localization assay; expression analysis across tissues and cell lines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 structural analysis with functional inference; single lab\",\n      \"pmids\": [\"15201283\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Crystal structure of DUSP23/VHZ at 1.93 Å resolution reveals a shallow active site cleft supporting dual phosphosubstrate specificity; Thr135-Tyr136 from a symmetry-related molecule mimics the phosphorylated TY motif of the MAPK activation loop in an enzyme-substrate/product complex; functional analysis of Phe66, Leu97, and Phe99 residues illuminates substrate binding and catalysis; in vitro it dephosphorylates p44ERK1 but not p54SAPK-beta and can enhance JNK and p38 activation.\",\n      \"method\": \"X-ray crystallography (1.93 Å); site-directed mutagenesis of active-site residues; in vitro dephosphorylation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mutagenesis and in vitro functional validation in single study\",\n      \"pmids\": [\"18245086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DUSP23 interacts with the transcription factor GCM1 in a manner enhanced by PKA-dependent phosphorylation of GCM1 at Ser269 and Ser275; DUSP23 reverses GSK-3β-mediated phosphorylation of GCM1 at Ser322, thereby promoting GCM1 acetylation, stabilization, and activation of its target genes; DUSP23 knockdown suppresses GCM1 target gene expression and placental cell fusion.\",\n      \"method\": \"Co-immunoprecipitation; phosphorylation site mapping; siRNA knockdown with reporter gene assays; cell fusion assays in placental cells\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, knockdown with defined cellular phenotype, multiple orthogonal methods in single study\",\n      \"pmids\": [\"20855292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DUSP23/VHZ localizes to the centrosome (in addition to cytoplasm) and promotes G1/S cell cycle transition in a PTP activity-dependent manner; overexpression of catalytically active VHZ (but not C95S mutant) in MCF-7 cells promotes cell proliferation, while shRNA knockdown increases G1 and decreases S phase populations.\",\n      \"method\": \"Indirect immunofluorescence with centrosome markers; retroviral transduction of wild-type and C95S catalytic mutant; shRNA knockdown; cell cycle analysis by flow cytometry\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment, catalytic mutant control, loss-of-function with cell cycle readout; multiple orthogonal methods\",\n      \"pmids\": [\"20509867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DUSP23 knockdown decreases neuronal differentiation of mouse J1 embryonic stem cells, reducing neuronal outgrowth and expression of neuronal marker proteins and mRNAs.\",\n      \"method\": \"siRNA/shRNA knockdown during neuronal differentiation; expression profiling of 83 PTPs; measurement of neurite outgrowth and neuronal markers\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean knockdown with defined cellular phenotype; single lab, single paper\",\n      \"pmids\": [\"26704437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"DUSP23 promotes dephosphorylation of β-catenin at Tyr142, enhances the interaction between α- and β-catenin, and is required for E-cadherin adherens junction integrity; DUSP23 knockdown specifically diminishes adhesion to E-cadherin, produces zipper-like cell-cell adhesions, causes defects in polarization cue transmission, and reduces coordination during collective migration.\",\n      \"method\": \"Protein interaction mapping (AP-MS); DUSP23 knockdown; adhesion assays to E-cadherin vs fibronectin; phospho-specific antibodies for β-catenin pTyr142; live imaging of collective migration\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, specific substrate (β-catenin pTyr142) identified, loss-of-function with defined cellular phenotypes, interaction map\",\n      \"pmids\": [\"27255161\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DUSP23 promotes STAT3 phosphorylation in cisplatin-resistant NSCLC cells, thereby enhancing SOX2 transcription; DUSP23 knockdown impairs cancer stem cell-like cluster formation, reduces SOX2 expression, decreases invasive behavior, and induces apoptosis in cisplatin-resistant cells, and suppresses lung tumorigenesis in vivo.\",\n      \"method\": \"shRNA knockdown; ultra-low adhesion sphere formation assay; western blot for STAT3 phosphorylation and SOX2; in vivo xenograft model; apoptosis assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — knockdown with defined phenotype and mechanistic follow-up (STAT3/SOX2); single lab\",\n      \"pmids\": [\"41257937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"EZH2-mediated H3K27me3 enrichment on the DUSP23 gene promoter represses DUSP23 expression; upon EZH2 inhibition, increased DUSP23 mediates dephosphorylation of pSMAD3 (Ser423/425), reducing macrophage-to-myofibroblast transition and kidney fibrosis.\",\n      \"method\": \"ChIP sequencing; Co-IP and molecular docking of DUSP23 with pSMAD3; Ezh2 inducible knockout mice; GSK-126 EZH2 inhibitor treatment; immunofluorescence and flow cytometry\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP identifies epigenetic writer, Co-IP identifies substrate, in vivo genetic model; single lab\",\n      \"pmids\": [\"39987296\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DUSP23 (VHZ) is a 150-residue, cytoplasmic/centrosomal dual-specificity phosphatase whose shallow active site (defined crystallographically) dephosphorylates phosphotyrosine and phosphoserine/threonine residues on specific substrates including ERK1, GCM1-pSer322, β-catenin-pTyr142, and pSMAD3-Ser423/425, coordinating downstream signaling pathways that control placental cell fusion, epithelial cell-cell adhesion, G1/S cell cycle progression, neuronal differentiation, and cancer stem cell maintenance partly via STAT3-SOX2; its own expression is epigenetically silenced by EZH2-dependent H3K27me3.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"DUSP23 (VHZ) was identified as the smallest active protein-tyrosine phosphatase known (150 residues), containing a DSPc domain but lacking a CH2 domain. It was shown to be enzymatically active, dephosphorylating phospho-tyrosine and phospho-threonine substrates including p-nitrophenyl phosphate and p44ERK1 (but not p38 or p54SAPKbeta) in vitro. In transfected HEK293 cells, DUSP23 localizes to the cytoplasm.\",\n      \"method\": \"In vitro phosphatase assay with pNPP and oligopeptides; in vitro dephosphorylation of p44ERK1; RT-PCR expression analysis; transient transfection with subcellular localization\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple in vitro activity assays with defined substrates, replicated by subsequent structural studies\",\n      \"pmids\": [\"15147733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DUSP23 (VHZ) was independently characterized as the smallest active cysteine-based PTP, bearing the HCXXGXXRS(T) active site motif. It was shown to dephosphorylate phospho-Tyr and phospho-Ser/Thr residues and, unlike the related VHR, is unlikely to dephosphorylate MAP kinases based on surface charge distribution modeling. VHZ was found in cytosol and nucleoli of transfected cells.\",\n      \"method\": \"In vitro phosphatase assay; computer modeling of structure; subcellular localization in transfected cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 in vitro activity, Tier 4 structural (computational), single lab\",\n      \"pmids\": [\"15201283\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Crystal structure of DUSP23 (VHZ) was solved at 1.93 Å resolution, revealing a typical αβα PTP fold with a shallow active site cleft that supports dual-specificity. The Thr135-Tyr136 dipeptide from a symmetry-related molecule, together with a malate ion, occupied the active site mimicking the phosphorylated TY motif of the MAPK activation loop. Functional analysis of Phe66, Leu97, and Phe99 provided mechanistic insight into substrate binding and catalysis.\",\n      \"method\": \"X-ray crystallography (1.93 Å); enzyme-substrate/product complex analysis; functional mutagenesis of active site residues\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with enzyme-substrate/product complex and mutagenesis validation\",\n      \"pmids\": [\"18245086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DUSP23 (VHZ) was shown to localize to the centrosome in addition to the cytoplasm, as demonstrated by indirect immunofluorescence of both exogenous and endogenous VHZ. Overexpression of VHZ (but not the catalytically inactive VHZ-C95S mutant) in MCF-7 cells promoted cell proliferation; shRNA-mediated knockdown increased G1 and decreased S phase cell populations, indicating that VHZ facilitates G1/S cell cycle transition in a phosphatase-activity-dependent manner.\",\n      \"method\": \"Indirect immunofluorescence; retroviral overexpression and shRNA knockdown; cell proliferation assay; cell cycle analysis by flow cytometry\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional consequence, catalytic mutant control, multiple cell-based assays\",\n      \"pmids\": [\"20509867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DUSP23 was identified as a phosphatase for GCM1, a transcription factor essential for placental development. DUSP23 interaction with GCM1 is enhanced by PKA-dependent phosphorylation of GCM1 on Ser269 and Ser275. Recruited DUSP23 reverses GSK-3β-mediated phosphorylation of GCM1 Ser322, which promotes GCM1 acetylation, stabilization, and transcriptional activation. Knockdown of DUSP23 suppressed GCM1 target gene expression and placental cell fusion.\",\n      \"method\": \"Co-immunoprecipitation; phosphorylation/dephosphorylation assays; shRNA knockdown; placental cell fusion assay; reporter gene assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, substrate dephosphorylation assay, KD with defined cellular phenotype (cell fusion), multiple orthogonal methods\",\n      \"pmids\": [\"20855292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DUSP23 expression increases during neuronal differentiation of mouse embryonic stem cells. Knockdown of DUSP23 decreased neuronal differentiation as measured by reduced neuronal outgrowth and decreased expression of neuronal marker proteins and mRNAs.\",\n      \"method\": \"Expression profiling (RT-PCR/Western blot); shRNA knockdown; neuronal outgrowth assay; neuronal marker protein/mRNA quantification during differentiation\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with defined cellular phenotype, but single lab and limited mechanistic pathway placement\",\n      \"pmids\": [\"26704437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"DUSP23 was identified as a phosphatase for β-catenin at Tyr142, promoting dephosphorylation of this residue and enhancing the interaction between α- and β-catenin. DUSP23 knockdown specifically diminished adhesion to E-cadherin (without altering fibronectin adhesion), produced 'zipper-like' cell-cell adhesions, caused defects in transmission of polarization cues, and reduced coordination during collective cell migration.\",\n      \"method\": \"Protein interaction mapping (affinity purification-MS); DUSP23 knockdown; β-catenin pTyr142 phosphorylation assay; E-cadherin adhesion assay; live-cell imaging of collective migration\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — substrate identified by AP-MS and validated by phospho-specific assay, KD with multiple defined cellular phenotypes\",\n      \"pmids\": [\"27255161\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DUSP23 promotes cancer stem cell-like properties and chemoresistance in non-small cell lung cancer by positively regulating STAT3 phosphorylation, thereby enhancing SOX2 transcription. DUSP23 knockdown impaired cell cluster formation under ultra-low adhesion conditions, suppressed SOX2 expression, decreased invasive behavior in cisplatin-resistant cells, and induced apoptosis. DUSP23 knockdown also suppressed lung tumorigenesis in vivo.\",\n      \"method\": \"shRNA knockdown; STAT3 phosphorylation assay; SOX2 transcription/protein assay; cluster formation assay; invasion assay; apoptosis assay; in vivo xenograft\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with defined phenotype and pathway placement (STAT3/SOX2), single lab\",\n      \"pmids\": [\"41257937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"EZH2-mediated H3K27me3 enrichment on the DUSP23 promoter suppresses DUSP23 expression. When EZH2 is inhibited, DUSP23 expression is elevated. DUSP23 was shown by Co-IP and molecular docking to mediate dephosphorylation of pSMAD3 (Ser423/425), thereby attenuating macrophage-to-myofibroblast transition and kidney fibrosis in a nephrocalcinosis model.\",\n      \"method\": \"ChIP-seq; Co-immunoprecipitation; molecular docking; EZH2 knockout/inhibition (GSK-126); transcriptomic sequencing; immunofluorescence; flow cytometry\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP substrate identification (pSMAD3) with ChIP-based upstream regulation, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"39987296\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DUSP23 (VHZ) is a small (150 aa) catalytically active dual-specificity phosphatase with an αβα PTP fold and shallow active site that dephosphorylates phospho-Tyr and phospho-Ser/Thr residues on substrates including ERK1, GCM1 (Ser322), β-catenin (Tyr142), and pSMAD3 (Ser423/425); it localizes to the cytoplasm and centrosome, promotes G1/S cell cycle progression and cell proliferation in a catalytic-activity-dependent manner, coordinates GCM1 stabilization and placental cell fusion by counteracting GSK-3β phosphorylation, maintains E-cadherin-based adherens junctions through β-catenin dephosphorylation, supports neuronal differentiation, and promotes cancer stem cell-like properties and chemoresistance via STAT3/SOX2 signaling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DUSP23 (VHZ) is a minimal dual-specificity phosphatase that dephosphorylates both phosphotyrosine and phosphoserine/threonine residues on diverse substrates to regulate cell fusion, adhesion, proliferation, and differentiation. Its 1.93 Å crystal structure reveals a shallow active-site cleft that accommodates both phospho-Tyr and phospho-Thr/Ser substrates, and catalytic activity depends on Cys95 within the conserved PTP motif [PMID:18245086, PMID:15147733]. Characterized substrates include ERK1, GCM1-pSer322 (whose dephosphorylation stabilizes GCM1 and promotes placental syncytiotrophoblast fusion), β-catenin-pTyr142 (whose dephosphorylation strengthens α-/β-catenin interaction and E-cadherin–based adherens junctions), and pSMAD3-Ser423/425 (whose dephosphorylation opposes macrophage-to-myofibroblast transition and kidney fibrosis) [PMID:20855292, PMID:27255161, PMID:39987296]. DUSP23 localizes to the cytoplasm and centrosome, promotes G1/S cell-cycle progression in a catalytic-activity-dependent manner, and its expression is epigenetically silenced by EZH2-mediated H3K27me3 [PMID:20509867, PMID:39987296].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Establishing that DUSP23 is a catalytically active dual-specificity phosphatase with selectivity for ERK1 over p38/SAPK answered the foundational question of whether this minimal PTP-fold protein possesses enzymatic activity and any substrate preference.\",\n      \"evidence\": \"In vitro phosphatase assays using pNPP and phospho-peptide substrates; RT-PCR; transient transfection in HEK293 cells\",\n      \"pmids\": [\"15147733\", \"15201283\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"ERK1 dephosphorylation shown only in vitro; physiological relevance not demonstrated\",\n        \"Surface charge analysis suggested MAPK dephosphorylation may not be the primary in vivo function\",\n        \"No endogenous substrates identified\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The 1.93 Å crystal structure resolved how a 150-residue phosphatase achieves dual specificity: a shallow active-site cleft accommodates both pTyr and pThr, and a symmetry-related Thr-Tyr dipeptide mimics the MAPK activation loop, defining the structural basis of substrate recognition.\",\n      \"evidence\": \"X-ray crystallography with site-directed mutagenesis (Phe66, Leu97, Phe99) and in vitro dephosphorylation assays\",\n      \"pmids\": [\"18245086\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No co-crystal with a full-length physiological substrate\",\n        \"Mechanism by which VHZ enhances JNK/p38 activation unexplained\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Two studies identified the first physiological substrate and cellular functions: DUSP23 dephosphorylates GCM1-pSer322 to stabilize GCM1 and drive placental cell fusion, and independently localizes to the centrosome to promote G1/S transition in a catalytic-activity-dependent manner.\",\n      \"evidence\": \"Co-IP and siRNA knockdown with cell fusion assays in placental cells; immunofluorescence with centrosome markers, catalytic-dead C95S mutant, and flow cytometry in MCF-7 cells\",\n      \"pmids\": [\"20855292\", \"20509867\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Centrosomal substrate(s) driving G1/S transition not identified\",\n        \"Relationship between centrosomal localization and GCM1 regulation unclear\",\n        \"PKA-dependent modulation of DUSP23-GCM1 interaction not tested in vivo\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Knockdown experiments established that DUSP23 is required for neuronal differentiation of embryonic stem cells, extending its functional repertoire beyond proliferation and fusion.\",\n      \"evidence\": \"siRNA/shRNA knockdown during J1 mouse ES cell neuronal differentiation; neurite outgrowth and marker quantification\",\n      \"pmids\": [\"26704437\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Substrate mediating neuronal differentiation not identified\",\n        \"Single-lab finding not independently replicated\",\n        \"Whether catalytic activity is required was not tested\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identification of β-catenin-pTyr142 as a DUSP23 substrate explained how this phosphatase reinforces E-cadherin adherens junctions and coordinates collective cell migration.\",\n      \"evidence\": \"AP-MS interaction mapping; phospho-specific antibodies for β-catenin pTyr142; DUSP23 knockdown with adhesion assays and live imaging of collective migration\",\n      \"pmids\": [\"27255161\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Upstream kinase phosphorylating β-catenin Tyr142 in this context not addressed\",\n        \"In vivo significance for tissue morphogenesis not tested\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Two studies broadened the substrate repertoire and regulatory context: DUSP23 dephosphorylates pSMAD3-Ser423/425 to oppose kidney fibrosis and is itself epigenetically silenced by EZH2-dependent H3K27me3; separately, DUSP23 promotes STAT3 phosphorylation and SOX2 transcription to maintain cancer stemness in cisplatin-resistant NSCLC.\",\n      \"evidence\": \"ChIP-seq for H3K27me3 at DUSP23 promoter; Ezh2 inducible knockout mice; Co-IP and molecular docking with pSMAD3; shRNA knockdown with sphere formation, xenograft, and STAT3/SOX2 western blots in NSCLC cells\",\n      \"pmids\": [\"39987296\", \"41257937\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"STAT3 promotion appears paradoxical for a phosphatase — direct vs. indirect mechanism not resolved\",\n        \"Both findings from single labs, not independently replicated\",\n        \"Whether EZH2-DUSP23 axis operates in tissues beyond kidney macrophages is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The centrosomal substrate(s) responsible for DUSP23-driven G1/S progression remain unidentified, the apparently opposing roles of DUSP23 as a phosphatase that nonetheless promotes STAT3 phosphorylation are mechanistically unresolved, and no structural basis for substrate selectivity among its diverse targets (GCM1, β-catenin, SMAD3) has been established.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No co-crystal structure with any physiological substrate\",\n        \"Selectivity determinants among multiple substrates unknown\",\n        \"STAT3 activation mechanism (direct or indirect) unresolved\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 3, 4, 6, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1, 4]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2, 6, 7, 8]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GCM1\",\n      \"CTNNB1\",\n      \"SMAD3\",\n      \"MAPK3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"DUSP23 (VHZ) is the smallest known catalytically active cysteine-based protein tyrosine phosphatase (150 residues), functioning as a dual-specificity phosphatase that dephosphorylates both phospho-Tyr and phospho-Ser/Thr residues on a growing list of substrates including ERK1, GCM1 (Ser322), β-catenin (Tyr142), and pSMAD3 (Ser423/425) [PMID:15147733, PMID:20855292, PMID:27255161, PMID:39987296]. Its crystal structure reveals an αβα PTP fold with a characteristically shallow active-site cleft that accommodates both pTyr and pSer/pThr substrates [PMID:18245086]. DUSP23 localizes to the cytoplasm and centrosome, promotes G1/S cell-cycle progression in a catalytic-activity-dependent manner, maintains E-cadherin-based adherens junctions through β-catenin Tyr142 dephosphorylation, coordinates GCM1 stabilization and placental cell fusion by counteracting GSK-3β phosphorylation, and supports neuronal differentiation [PMID:20509867, PMID:27255161, PMID:20855292, PMID:26704437]. In non-small cell lung cancer, DUSP23 promotes cancer stem cell-like properties and chemoresistance via positive regulation of STAT3 phosphorylation and SOX2 transcription [PMID:41257937].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Identification of DUSP23 as the smallest active dual-specificity phosphatase established it as a bona fide enzyme capable of dephosphorylating pTyr and pThr substrates, including ERK1 but not p38 or SAPK, and placed it in the cytoplasm.\",\n      \"evidence\": \"In vitro phosphatase assays with pNPP, oligopeptide substrates, and recombinant p44ERK1; subcellular localization in transfected HEK293 cells; independent characterization confirming dual-specificity and noting cytosol/nucleolar localization\",\n      \"pmids\": [\"15147733\", \"15201283\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"In vivo substrates beyond ERK1 not yet identified\",\n        \"Physiological relevance of nucleolar localization not addressed\",\n        \"No structural data to explain substrate selectivity\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The crystal structure at 1.93 Å resolution revealed how DUSP23's shallow active site cleft accommodates both pTyr and pSer/pThr substrates, resolving the structural basis for its dual specificity and identifying key catalytic residues (Phe66, Leu97, Phe99).\",\n      \"evidence\": \"X-ray crystallography with enzyme-substrate/product complex mimicked by Thr135-Tyr136 dipeptide and malate ion; functional mutagenesis of active-site residues\",\n      \"pmids\": [\"18245086\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No co-crystal with a physiological substrate\",\n        \"Structural basis for selectivity against p38/SAPK not fully resolved\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery of centrosomal localization and catalytic-activity-dependent promotion of G1/S transition answered how DUSP23 participates in cell proliferation and revealed a centrosome-associated function, while identification of GCM1 Ser322 as a substrate linked DUSP23 to placental cell fusion through antagonism of GSK-3β.\",\n      \"evidence\": \"Indirect immunofluorescence of endogenous/exogenous protein; catalytically dead C95S mutant control; shRNA knockdown with cell-cycle and cell-fusion phenotypes; Co-IP and dephosphorylation assays for GCM1\",\n      \"pmids\": [\"20509867\", \"20855292\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Centrosomal substrate(s) not identified\",\n        \"Mechanism linking DUSP23 to G1/S regulators not defined\",\n        \"Whether GCM1 dephosphorylation is direct at physiological stoichiometry not fully confirmed\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstration that DUSP23 is upregulated during and required for neuronal differentiation of mouse embryonic stem cells extended its functional scope beyond proliferation to a developmental lineage commitment role.\",\n      \"evidence\": \"shRNA knockdown during mESC neuronal differentiation; neuronal outgrowth and marker expression quantification\",\n      \"pmids\": [\"26704437\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Downstream substrate(s) mediating the differentiation phenotype not identified\",\n        \"Not independently replicated\",\n        \"Limited mechanistic pathway placement\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identification of β-catenin Tyr142 as a direct DUSP23 substrate explained how it maintains E-cadherin-based adherens junctions and coordinates collective cell migration, establishing a cell-adhesion function.\",\n      \"evidence\": \"Affinity purification–mass spectrometry interaction mapping; pTyr142-specific phosphorylation assays; DUSP23 knockdown with E-cadherin adhesion, polarity, and migration phenotypes\",\n      \"pmids\": [\"27255161\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether DUSP23 regulates β-catenin transcriptional (Wnt) signaling in addition to adhesion not tested\",\n        \"Tissue-specific relevance of this function not explored\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Two studies expanded DUSP23's substrate repertoire and disease-context roles: DUSP23 promotes cancer stemness and chemoresistance in NSCLC via STAT3/SOX2 signaling, and DUSP23 dephosphorylates pSMAD3 (Ser423/425) to attenuate macrophage-to-myofibroblast transition in kidney fibrosis, with its expression regulated by EZH2-mediated H3K27me3.\",\n      \"evidence\": \"shRNA knockdown in cisplatin-resistant NSCLC cells with in vivo xenograft; Co-IP and molecular docking for pSMAD3; ChIP-seq for EZH2-mediated promoter silencing; nephrocalcinosis model\",\n      \"pmids\": [\"41257937\", \"39987296\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Paradoxical promotion of STAT3 phosphorylation by a phosphatase requires mechanistic explanation — indirect mechanism not delineated\",\n        \"pSMAD3 as substrate validated by Co-IP and docking but not by in vitro reconstitution with purified proteins\",\n        \"Both studies from single laboratories, awaiting independent replication\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DUSP23 achieves substrate selectivity across its diverse substrates (ERK1, GCM1, β-catenin, SMAD3, STAT3 pathway), what its centrosomal substrate(s) are, and whether its apparently contradictory pro-phosphorylation effect on STAT3 is indirect remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No systematic substrate profiling or phospho-proteomics performed\",\n        \"Centrosomal interactors and substrates unknown\",\n        \"No in vivo genetic model (knockout mouse) reported\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 2, 4, 6, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 4, 6, 7, 8]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GCM1\",\n      \"CTNNB1\",\n      \"SMAD3\",\n      \"MAPK3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}